Mar 09, 2022 / 09:30PM GMT
Operator
Welcome to Acorda Therapeutics Fourth Quarter 2021 Financial and Business Update. (Operator Instructions) Please be advised that this call is being taped at the company's request.
I will now introduce you to our host, Tierney Saccavino, Executive Vice President, Corporate Communications at Acorda. Please go ahead.
Tierney Saccavino -
Thank you, Tania, and good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings which are public, and we encourage you to refer filings.
During today's Q&A, we will first take calls from our analysts, and then we will take some questions that other investors have written in when they registered for the call.
I will now pass the call over to our CEO, Ron Cohen. Ron?
Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director
Thank you, Tierney, and welcome, everyone. We'll dive right in. At the beginning of 2021, we established
Q4 2021 Acorda Therapeutics Inc Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers